about
Gingival fibromatosis: clinical, molecular and therapeutic issuesDrugs and oral disorders.The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts.Prevalence of gingival overgrowth induced by antihypertensive drugs: A hospital-based study.Dermal connective tissue modulated by pharmacologic agents.Angiotensin II Levels in Gingival Tissues from Healthy Individuals, Patients with Nifedipine Induced Gingival Overgrowth and Non Responders on NifedipineGingival overgrowth in children: epidemiology, pathogenesis, and complications. A literature review.Effects of medications on the periodontal tissues in health and disease.Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosisFactors associated with gingival inflammation among adults with systemic sclerosis.Natural resolution of inflammation.Systemic medication and the inflammatory cascade.Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression.Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease: A Case-Control Study.Non-surgical pocket therapy: pharmacotherapeutics.Effect of phenytoin and age on gingival fibroblast enzymes.Cyclosporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva.The role of inflammation and apoptosis in cyclosporine A-induced gingival overgrowth.Chronic renal failure and periodontal disease.Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs.Keratinocyte growth factor receptor is up-regulated in cyclosporin A-induced gingival hyperplasia.Inhibition of cyclosporin A-induced gingival overgrowth by azithromycin through phagocytosis: an in vivo and in vitro study.Relationship of subgingival and salivary microbiota to gingival overgrowth in heart transplant patients following cyclosporin A therapy.Tetracycline fibers as an adjunct in the treatment of nifedipine-induced gingival enlargement.Proliferation of fibroblasts cultured from normal gingiva and hereditary gingival fibromatosis is dependent on fatty acid synthase activity.Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth.Host modulation therapy with anti-inflammatory agents.Preemptive and Postoperative Medication Protocols for Root Coverage Combined with Connective Tissue Graft.The clinical effects of nifedipine on periodontal status.Longitudinal association between plaque and gingival bleeding in smokers and non-smokers.Cyclosporine a inhibits apoptosis of rat gingival epithelium.Immunohistochemical Analysis of Lymphocyte Subpopulations in Cyclosporin A-Induced Gingival Overgrowth
P2860
Q28067236-50EDB494-3F68-4C40-9BBF-837EED72DAC4Q33592359-BAEB7554-E6BC-443F-9B81-AAB5626C9AC9Q33768650-69EDB3BF-886E-4EA8-A77D-0ADEB3F38416Q35902982-B009DFE2-7901-440C-90D4-1153AEB7CA74Q36028172-5A731B40-ECC0-4B09-ADA7-40385F77CA4EQ36077646-DD92B4DB-0DD8-46E2-B7CB-59429EFCE5D1Q36097981-20E11485-A969-462A-A000-2004FB9A4071Q36362702-F6DC7AA1-CF75-4061-8972-18C43C291E23Q36460892-C8B16F59-0CE7-4EDF-B568-E297C3E6A308Q37045999-78E0C520-D93F-48EB-BF4D-FBB9D8E7CCB2Q38127782-DF2D4421-B953-4E45-866C-6C06AA37D1E4Q38169806-A41765CB-FA6E-4A37-84EC-D1FDCF73473EQ40877516-F1786908-1A70-4655-9400-D0DB4B8F595AQ40928170-4914BF19-4CBB-4D00-8C7A-A99091E14084Q41444909-080FF487-EFDB-44D4-B134-598ADF9D3A28Q41515803-E16FE453-7805-494A-AE0D-BBA8DA42E871Q42555314-CC2131DE-8FE8-4D2B-B57D-EF61806C3659Q43154272-6B081C95-C722-4912-92D5-0A1F04602C61Q43704528-3CD5DC1A-ED49-4CA8-A551-AFF6FCE872B9Q43758702-FF1199D4-F10E-4497-BA59-810E600A5ABAQ44156068-1CA2F326-1B6E-4A0B-B69A-4CF038848E6CQ44847442-3696F085-DC4A-4BB3-AA13-8CD51FF7647AQ45039856-6C18C8C1-0388-471A-A70A-FBDC1C46C069Q46538941-57D3C36B-308B-47C6-9247-9CFEB6646011Q46563385-3AD34635-7E04-46D4-991F-85538154FB29Q46760702-F7ECCB75-09B0-46A4-987D-4FA0EA5173EFQ48585276-93AC8BAC-8847-48C5-A541-6A2938E5EAF5Q50135578-6FCD6C3A-6655-4CA1-A269-7D868F3EA5FEQ50898718-A6CC7D2F-AD75-43B5-95B7-0506BA306A9AQ52042415-325B7CC7-A9E1-4180-AA27-B647BF633AB2Q53082214-9342EB69-9742-4ED1-AD2C-A7CC7BCFCA65Q58630830-8B4455CE-51CE-466D-840B-C2098EF9716A
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Drugs and the periodontium.
@en
Drugs and the periodontium.
@nl
type
label
Drugs and the periodontium.
@en
Drugs and the periodontium.
@nl
prefLabel
Drugs and the periodontium.
@en
Drugs and the periodontium.
@nl
P2860
P1476
Drugs and the periodontium.
@en
P2093
Heasman PA
Seymour RA
P2860
P356
10.1111/J.1600-051X.1988.TB01549.X
P407
P577
1988-01-01T00:00:00Z